Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with a type of lung cancer called non-small cell lung cancer (NSCLC), confirmed by a lab test on a tissue or cell sample
- Your lung cancer has a specific gene change (mutation) in the EGFR gene — either an "exon 19 deletion" or an "exon 21 L858R mutation" (confirm with trial site if unsure which type you have)
- Your cancer has spread to the fluid surrounding your brain and spinal cord (called leptomeningeal metastasis), confirmed by a spinal fluid test done within 28 days before starting the trial, and there is at least one affected area that can be monitored by MRI scans
- Your cancer got worse after being treated with a first type of targeted therapy drug (called a tyrosine kinase inhibitor or TKI)
- You are between 18 and 85 years old (any gender)
- Your blood counts, liver, and kidney are working well enough, as shown by standard blood tests (the trial team will check these specific levels)
- If you are taking part in the drug absorption/processing part of the study: you have never previously been treated with a specific drug called furmonertinib
- You are willing to follow the treatment plan, take medications as directed, and have signed a consent form agreeing to take part
Who may not be able to join:
- You are unable to fill in the required health questionnaires at the start of the trial
- You have a serious or uncontrolled illness alongside your cancer, such as an active infection, abnormal blood salt levels, or a bleeding problem
- You are pregnant, breastfeeding, or planning to become pregnant during the study or within 6 months after it ends
- You have a brain complication that needs urgent brain surgery
- You currently have, or have previously had, another type of cancer
- You have a serious brain condition or mental illness that would prevent you from reporting your own symptoms
- You do not have the legal ability to make your own decisions, or there are medical or ethical reasons that would make continuing the study inappropriate
- The trial doctors decide for any other reason that the trial is not right for you
- You have a history of severe allergies, particularly if you had a serious allergic or adverse reaction to a TKI (targeted therapy) drug in the past
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Haibo Zhang, M.D., Guangdong Provincial Hospital of Traditional Chinese Medicine
Phone: 86-20-81887233
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
LM-DCR
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.